Chloropyramine increases NSCLC sensitivity to cisplatin in a SASH1 dependent manner. (January 2019) - Burgess, J.; Bolderson, E.; Adams, M.; Zhang, S.; Fox, S.; Wright, G.; Young, R.; Solomon, B.; Gray, S.; Richard, D.; O'Byrne, K.